Home > Insider Trading > Filing (0001474064-13-000062)

Filing Details

Accession Number:: 0001474064-13-000062
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-10 18:18:45
Reporting Period:: 2013-04-09

Filing Date:: 2013-04-10
Accepted Time:: 2013-04-10 18:18:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
890465	Nps Pharmaceuticals Inc	NPSP	Biological Products, (No Disgnostic Substances) (2836)	870439579

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1299691	J Joseph Rogus	550 Hills Drive Bedminster NJ 07921	Vp, Technical Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-04-09	5,175	$5.85	24,547	No	4	M	Direct
Common Stock	Acquisiton	2013-04-09	7,374	$5.71	31,921	No	4	M	Direct
Common Stock	Acquisiton	2013-04-09	25,396	$5.71	57,317	No	4	M	Direct
Common Stock	Acquisiton	2013-04-09	7,195	$3.34	64,512	No	4	M	Direct
Common Stock	Acquisiton	2013-04-09	2,875	$3.34	67,387	No	4	M	Direct
Common Stock	Disposition	2013-04-09	48,015	$11.50	19,372	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2013-04-09	5,175	$0.00	5,175	$5.85
Common Stock	Stock Option	Disposition	2013-04-09	7,374	$0.00	7,374	$5.71
Common Stock	Stock Option	Disposition	2013-04-09	25,396	$0.00	25,396	$5.71
Common Stock	Stock Option	Disposition	2013-04-09	7,195	$0.00	7,195	$3.34
Common Stock	Stock Option	Disposition	2013-04-09	2,875	$0.00	2,875	$3.34

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2018-10-15	No	4	M	Direct
2019-01-20	No	4	M	Direct
2019-01-20	No	4	M	Direct
2020-02-19	No	4	M	Direct
2020-02-19	No	4	M	Direct

Footnotes

The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective December 6, 2012.
On October 15, 2008, the Reporting Person received a grant of 5,175 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month for the next three years.
On January 20, 2009, the Reporting Person received a grant of 7,374 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.
On January 20, 2009, the Reporting Person received a grant of 25,396 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.
On February 19, 2010, the Reporting Person received a grant of 7,195 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.
On February 19, 2010, the Reporting Person was granted options to purchase shares of Common Stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. On February 17, 2011, the performance criteria for 11,500 of these options had been satisfied because the Issuer's Phase 3 pivotal study of GATTEX (teduglutide) had met the primary efficacy endpoint of reducing parenteral nutrition dependence in patients with adult short bowel syndrome. These 11,500 options will vest and become exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.